These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7711390)

  • 1. A pilot study of gonadotrophin releasing hormone agonist (GnRHa)/superovulation/donor intrauterine insemination (IUI) after unsuccessful artificial insemination with donor sperm (DI).
    Hercz P; Walker SM; Wells C; Gregory L
    J Assist Reprod Genet; 1994 May; 11(5):278-80. PubMed ID: 7711390
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors responsible for multiple pregnancies after ovarian stimulation and intrauterine insemination with gonadotropins.
    Valbuena D; Simón C; Romero JL; Remohí J; Pellicer A
    J Assist Reprod Genet; 1996 Sep; 13(8):663-8. PubMed ID: 8897127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of pre-ovulatory gonadotrophin surge with gonadotrophin-releasing hormone agonist compared to pre-ovulatory injection of human chorionic gonadotrophins for ovulation induction in intrauterine insemination treatment cycles.
    Shalev E; Geslevich Y; Matilsky M; Ben-Ami M
    Hum Reprod; 1995 Sep; 10(9):2244-7. PubMed ID: 8530644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of ovulation induction with and without intrauterine insemination in the treatment of unexplained infertility.
    Chung CC; Fleming R; Jamieson ME; Yates RW; Coutts JR
    Hum Reprod; 1995 Dec; 10(12):3139-41. PubMed ID: 8822431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial.
    Lambalk CB; Leader A; Olivennes F; Fluker MR; Andersen AN; Ingerslev J; Khalaf Y; Avril C; Belaisch-Allart J; Roulier R; Mannaerts B
    Hum Reprod; 2006 Mar; 21(3):632-9. PubMed ID: 16361296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of the use of gonadotropin-releasing hormone analog for triggering ovulation.
    Tulchinsky D; Nash H; Brown K; Paoletti-Falcone V; Polcaro J
    Fertil Steril; 1991 Mar; 55(3):644-6. PubMed ID: 1900489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
    Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
    J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol.
    Smitz J; Erard P; Camus M; Devroey P; Tournaye H; Wisanto A; Van Steirteghem AC
    Hum Reprod; 1992 Oct; 7(9):1225-9. PubMed ID: 1479002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine composition of follicular fluid comparing human chorionic gonadotrophin to a gonadotrophin-releasing hormone agonist for ovulation induction.
    Yding Andersen C; Westergaard LG; Figenschau Y; Bertheussen K; Forsdahl F
    Hum Reprod; 1993 Jun; 8(6):840-3. PubMed ID: 8345072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of over-response to ovarian stimulation in an intrauterine insemination programme.
    Lashen H; Afnan M; McDougall L; Clark P
    Hum Reprod; 1999 Nov; 14(11):2751-4. PubMed ID: 10548616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of ovulation in female rats treated with FSH at the beginning of the estrous cycle: changes in pituitary responsiveness to luteinizing hormone releasing hormone (LHRH).
    Geiger JM; Plas-Roser S; Aron C
    Biol Reprod; 1980 May; 22(4):837-45. PubMed ID: 6772247
    [No Abstract]   [Full Text] [Related]  

  • 12. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.
    Humaidan P; Ejdrup Bredkjaer H; Westergaard LG; Yding Andersen C
    Fertil Steril; 2010 Feb; 93(3):847-54. PubMed ID: 19200959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH agonist triggering: recent developments.
    Kol S; Humaidan P
    Reprod Biomed Online; 2013 Mar; 26(3):226-30. PubMed ID: 23337420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incomplete androgen and progesterone suppression following midluteal GnRHa prior to controlled ovarian hyperstimulation for IVF-ET.
    Gelety TJ; Surrey ES
    J Assist Reprod Genet; 1997 Oct; 14(9):525-30. PubMed ID: 9401871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the addition of a gonadotropin-releasing hormone agonist improve the pregnancy rate in intrauterine insemination? A prospective controlled trial.
    Eskandar MA
    Gynecol Endocrinol; 2007 Oct; 23(10):551-5. PubMed ID: 17891598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine insemination results in couples requiring extended semen transport time.
    Randall GW; Gantt PA
    Int J Fertil Womens Med; 2007; 52(1):28-34. PubMed ID: 17987885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist.
    Ragni G; Vegetti W; Baroni E; Colombo M; Arnoldi M; Lombroso G; Crosignani PG
    Hum Reprod; 2001 Nov; 16(11):2258-62. PubMed ID: 11679500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of HMG/HCG superovulation for AID with or without superactive GnRH agonist.
    Gerris J; Jacquemyn Y; Desmedt E; Delbeke L; Buytaert P
    Hum Reprod; 1989 Nov; 4(8):937-40. PubMed ID: 2515211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superovulation strategy before in vitro fertilization.
    Hillier SG; Afnan AM; Margara RA; Winston RM
    Clin Obstet Gynaecol; 1985 Sep; 12(3):687-723. PubMed ID: 3933880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-finding study of Leuplin depot for prevention of premature luteinizing hormone surge during controlled ovarian stimulation: a pilot study in intrauterine insemination treatment.
    Chen HJ; Lin YH; Huang MZ; Seow KM; Huang LW; Hsieh BC; Tzeng CR; Hwang JL
    Taiwan J Obstet Gynecol; 2016 Apr; 55(2):235-8. PubMed ID: 27125407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.